Order Article Reprints

Torres M, Corona M, Rodríguez-Mora S, Casado-Fernández G, Zurdo-Castronuño A, Mateos E, Ramos-Martín F, Sánchez-Menéndez C, Murciano-Antón MA, García-Pérez J, et al. Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster. Cancers. 2022; 14(22):5537. https://doi.org/10.3390/cancers14225537

Torres, Montserrat, Magdalena Corona, Sara Rodríguez-Mora, Guiomar Casado-Fernández, Alejandro Zurdo-Castronuño, Elena Mateos, Fernando Ramos-Martín, Clara Sánchez-Menéndez, María Aranzazú Murciano-Antón, Javier García-Pérez, and et al. 2022. "Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster" Cancers 14, no. 22: 5537. https://doi.org/10.3390/cancers14225537

Torres, M., Corona, M., Rodríguez-Mora, S., Casado-Fernández, G., Zurdo-Castronuño, A., Mateos, E., Ramos-Martín, F., Sánchez-Menéndez, C., Murciano-Antón, M. A., García-Pérez, J., Alcamí, J., Pérez-Olmeda, M., Coiras, M., López-Jiménez, J., García-Gutiérrez, V., & on behalf of the Multidisciplinary Group of Study of COVID-19 (MGS-COVID). (2022). Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster. Cancers, 14(22), 5537. https://doi.org/10.3390/cancers14225537